PMA device
Proclaim SCS Neurostimulation System
Abbott Medical · Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW, Class III) · First FDA decision Jan 19, 2021, newest Nov 17, 2021Chronic pain
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
2
Naming "Proclaim SCS Neurostimulation"
MAUDE reports
0
Brand "Proclaim SCS Neurostimulation", since 2015
PubMed studies
0
Mentioning "Proclaim SCS Neurostimulation"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Proclaim SCS Neurostimulation System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Proclaim SCS Neurostimulation SystemPMA supplement
P010032-S176 · Decided Nov 17, 2021 · 169 days after receipt · Normal 180 Day Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
- Proclaim SCS Neurostimulation SystemPMA supplement
P010032-S166 · Decided Jan 19, 2021 · 189 days after receipt · Normal 180 Day Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Proclaim SCS Neurostimulation", any status and sponsor, newest update first.
Nora VanegasAcademic, hospital or other
NCT03526991 · 10 participants · Start Aug 1, 2021 · Primary completion Feb 28, 2026
Device: Spinal Cord Stimulator (SCS) · For: Parkinson Disease
Sites: New York, New York; Houston, Texas
- LONG TERM EFFECTS OF SPINAL CORD STIMULATIONStatus unknown
Nora VanegasAcademic, hospital or other
NCT06272955 · 10 participants (planned) · Start Jan 4, 2024 · Primary completion Jun 30, 2025
Device: Spinal Cord Stimulator (SCS) · For: Parkinson Disease
Sites: Houston, Texas
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Proclaim SCS Neurostimulation", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LGW
301,867 reports: 79,174 malfunction, 220,939 injury, 1,642 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Eterna SCS IPG (Implantable Pulse Generator), Model Number 32400Open, Classified
Z-0458-2026 · Started Oct 6, 2025 · Posted by FDA Nov 7, 2025
Reason given: There is a potential issue affecting Eterna Spinal Cord Stimulation (SCS) Implantable Pulse Generators (IPGs), Model 32400 and Liberta RC Deep Brain Stimulation (DBS) Implantable Pulse Generators (IPGs), Model 62400 . These devicess may experience a loss of communication with the Clinician Programmer (CP) and/or the...
Cause as FDA categorized it: Process control · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
Z-2505-2023 · Started Jul 18, 2023 · Posted by FDA Sep 11, 2023
Reason given: Firm has received complaints from patients who are unable to exit MRI (Magnetic Resonance Imaging) mode on their IPGs (Implantable Pulse Generators).
Cause as FDA categorized it: Under Investigation by firm · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
Z-2506-2023 · Started Jul 18, 2023 · Posted by FDA Sep 11, 2023
Reason given: Firm has received complaints from patients who are unable to exit MRI (Magnetic Resonance Imaging) mode on their IPGs (Implantable Pulse Generators).
Cause as FDA categorized it: Under Investigation by firm · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
11 more recall records with a free account
Published research
The most relevant PubMed records for "Proclaim SCS Neurostimulation"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LGW.
- Precision Spinal Cord Stimulator (SCS) SystemsBoston Scientific Corp · PMA 2026
- Senza Spinal Cord Stimulation (SCS) SystemNevro Corporation · PMA 2025
- Saluda Medical Evoke SCS SystemSaluda Medical Pty, Ltd. · PMA 2026
- Master RestoreMedtronic Neuromodulation · PMA 2026
- RestoreMedtronic Neuromodulation · PMA 2025
- Genesis and Eon Family Neurostimulation (Ipg) SystemsAbbott Medical · PMA 2016
- Genesis Neurostimulation SystemAbbott Medical · PMA 2024
- Precision Spectra Spinal Cord Stimulator (SCS) SystemBoston Scientific Corp · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.